Literature DB >> 28871627

Important Aspects of Pharmacist-led Medication Reviews in an Acute Medical Ward.

Cille Bülow1, Kirstine Ullitz Faerch1, Helle Armandi1, Birgitte Nybo Jensen2, Jesper Sonne3, Hanne Rolighed Christensen3, Mikkel B Christensen3.   

Abstract

In some hospitals, clinical pharmacists review the medication to find drug-related problems (DRPs) in acutely admitted patients. We aimed to identify the nature of identified DRPs and investigate factors of potential importance for the clinical implementation of pharmacist suggestions. In 100 randomly selected medication review (MR) notes, we retrospectively evaluated the clinical implementation and classified (1) timing and communication of the review; (2) DRPs and related suggestions for the physician; and (3) DRPs' potential clinical relevance to patients as 'beneficial', 'somewhat beneficial', 'no relevance' or 'other relevance'. Of 327 DRPs (0-13 DRPs per patient), 42% were implemented. The clinical implementation was higher if the MR note was made prior to (instead of after) the physician's admission, and even higher if the suggestions were communicated verbally (instead of only in writing) to the physicians (44% versus 79%, p < 0.05). The clinical relevance of the DRPs was either 'beneficial' (16%), 'somewhat beneficial' (43%), 'no relevance' (22%) or 'other relevance' (19%). The 'beneficial' DRPs had a higher clinical implementation (53%) than 'no relevance' (34%) (p < 0.05). The most frequently implemented suggestions were based on DRPs concerning 'indication for drug treatment not noticed', 'inappropriate drug form' and 'drug dose too low', with implementation rates of 83%, 67% and 63%, respectively. In our sample, the pharmacist's MR suggestions were only implemented by physicians in 42% of the cases, but review prior to physician contact and verbal communication of the suggestions, higher clinical relevance and specific types of DRPs were associated with a higher implementation rate.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Year:  2017        PMID: 28871627     DOI: 10.1111/bcpt.12901

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Bedside medication review with cognitive and depression screening by a clinical pharmacist as part of a comprehensive geriatric assessment in hospitalized older patients with polypharmacy: A pilot study.

Authors:  Veerle Mertens; Leen Jacobs; Nicole Knops; Seyedeh Malihe Alemzadeh; Kay Vandeven; Jo Swartenbroekx; Greta Moorkens; Maurits Vandewoude
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

2.  Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews.

Authors:  Rafaella de Oliveira Santos Silva; Luana Andrade Macêdo; Genival Araújo Dos Santos; Patrícia Melo Aguiar; Divaldo Pereira de Lyra
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

3.  A Collaborative Medication Review Including Deprescribing for Older Patients in an Emergency Department: A Longitudinal Feasibility Study.

Authors:  Morten Baltzer Houlind; Aino Leegaard Andersen; Charlotte Treldal; Lillian Mørch Jørgensen; Pia Nimann Kannegaard; Luana Sandoval Castillo; Line Due Christensen; Juliette Tavenier; Line Jee Hartmann Rasmussen; Mikkel Zöllner Ankarfeldt; Ove Andersen; Janne Petersen
Journal:  J Clin Med       Date:  2020-01-27       Impact factor: 4.241

4.  Causes of discrepancies between medications listed in the national electronic prescribing system and patients' actual use of medications.

Authors:  Cille Bülow; Josefine D S V Noergaard; Kirstine Ullitz Faerch; Caroline Pontoppidan; Janne Unkerskov; Karl Sebastian Johansson; Jonatan Kornholt; Mikkel B Christensen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-06-28       Impact factor: 4.080

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.